Live Quote · NASDAQVERVHealthcare· Biotechnology

Verve Therapeutics, Inc.

$11.13▲ 0.27%(+$0.03)
MKT CAP $994.04MLAST EARNINGS Aug 14, 2025
50%
Bullish
TickerSpark Score
73/100
▌ Solid
47
Valuation
40
Profitability
95
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VERV research report →

Analyst Price Target
$18.00+61.7% vs. today

Range $13 – $30

Analyst RatingHold
4 Buy8 Hold1 Sell

Price Chart

+44.55% · this period
$11.38$7.18$2.97Jul 23Jan 23Jul 24
52-Week Range97% of range
Low
$2.87
Current
$11.13
High
$11.40